hgs1029
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2008 (NCT00708006)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Inhibitor of apoptosis protein 3INHIBITOR
XIAP inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- hgs1029
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01013818 | Phase 1 | Oct 1, 2009 | GlaxoSmithKline, Human Genome Sciences |
| NCT00708006 | Phase 1 | May 1, 2008 | Human Genome Sciences |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Human Genome Sciences | For profit | 2 | 2 | 1 | 2008 |
| GlaxoSmithKline | For profit | 1 | 0 | 1 | 2009 |
2 organizations
Page 1 / 1